In this StockCharts TV video, Mary Ellen reviews the broader markets, takes a close look at NVDA and other year-to-date winners that sold off…
Stocks
-
-
Moving averages are a crucial charting tool, but many of us aren’t getting the most out of them. In this edition of StockCharts TV‘s StockCharts…
-
Who would have thought a mid-week break would halt the stock market’s winning streak? Maybe the hot PMI reading leaked, or traders and…
-
In this edition of StockCharts TV‘s The Final Bar, Dave answers viewer questions on using technical indicators on leveraged and inverse ETFs like SOXL and…
-
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping…
-
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the…
-
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women…
-
Today on Fox Business Varney & Company, David Bahnsen (The Bahnsen Group) was asked if the current market reminded him of the Dot.com…
-
While the S&P 500 continues to move higher, the number of stocks participating to the upside continues to decline. In other words, Market…
-
Note to the reader: This is the twenty-fifth and final in a series of articles I’m publishing here, taken from my book, “Investing…